HK1207852A1 - Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors - Google Patents

Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors

Info

Publication number
HK1207852A1
HK1207852A1 HK15108502.7A HK15108502A HK1207852A1 HK 1207852 A1 HK1207852 A1 HK 1207852A1 HK 15108502 A HK15108502 A HK 15108502A HK 1207852 A1 HK1207852 A1 HK 1207852A1
Authority
HK
Hong Kong
Prior art keywords
radiopharmaceuticals
multimodal
labelled
precursors
quinoxaline derivatives
Prior art date
Application number
HK15108502.7A
Other languages
English (en)
Chinese (zh)
Inventor
Jean-Michel Chezal
Latifa Rbah-Vidal
Emilie Billaud
Philippe Auzeloux
Jean-Claude Madelmont
Aurelien Vidal
Elisabeth Miot-Noirault
Janine Papon
Aurelie Maisonial
Original Assignee
Cyclopharma Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclopharma Lab filed Critical Cyclopharma Lab
Publication of HK1207852A1 publication Critical patent/HK1207852A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22Tin compounds
    • C07F7/2208Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15108502.7A 2012-04-24 2015-08-31 Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors HK1207852A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12165413.1A EP2657213A1 (en) 2012-04-24 2012-04-24 Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors
PCT/IB2013/053106 WO2013160808A1 (en) 2012-04-24 2013-04-19 Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors

Publications (1)

Publication Number Publication Date
HK1207852A1 true HK1207852A1 (en) 2016-02-12

Family

ID=48536968

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108502.7A HK1207852A1 (en) 2012-04-24 2015-08-31 Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors

Country Status (8)

Country Link
US (1) US20150079000A1 (xx)
EP (2) EP2657213A1 (xx)
AU (1) AU2013254326B2 (xx)
DK (1) DK2841402T3 (xx)
ES (1) ES2616793T3 (xx)
HK (1) HK1207852A1 (xx)
IL (1) IL235122A (xx)
WO (1) WO2013160808A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014112747A1 (de) * 2014-09-04 2016-03-10 Eberhard Karls Universität Tübingen Medizinische Fakultät Verwendung eines Quinoxalinderivats in einem bildgebenden Verfahren
JP7339692B2 (ja) * 2019-03-29 2023-09-06 国立研究開発法人量子科学技術研究開発機構 放射性標識化合物の製造方法及び製造装置
GB202108605D0 (en) * 2021-06-16 2021-07-28 Ge Healthcare Uk Ltd Effect of water content

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642972B1 (fr) 1989-02-14 1994-08-05 Inst Nat Sante Rech Med Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation
US5911970A (en) 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
DE102004011720B4 (de) 2004-03-10 2008-04-03 Bayer Schering Pharma Aktiengesellschaft Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie
GB0428012D0 (en) * 2004-12-22 2005-01-26 Hammersmith Imanet Ltd Radiolabelling methods
CA2617319A1 (en) * 2005-06-24 2007-01-04 The Trustees Of The University Of Pennsylvania Radiolabeled-pegylation of ligands for use as imaging agents
EP2085390A1 (en) 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors

Also Published As

Publication number Publication date
AU2013254326B2 (en) 2017-02-02
ES2616793T3 (es) 2017-06-14
EP2657213A1 (en) 2013-10-30
EP2841402B1 (en) 2016-11-30
DK2841402T3 (da) 2017-02-20
US20150079000A1 (en) 2015-03-19
WO2013160808A1 (en) 2013-10-31
AU2013254326A1 (en) 2014-10-30
EP2841402A1 (en) 2015-03-04
IL235122A (en) 2017-01-31

Similar Documents

Publication Publication Date Title
HK1202545A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
IL237309A0 (en) Benzocyclooctyne compounds and uses thereof
HK1199023A1 (en) Substituted benzothienylpyrrolotriazines and uses thereof
EP2907802A4 (en) CYCLOPROPANAMINE COMPOUND AND USE THEREOF
HK1200822A1 (en) Substituted dipyridylamines and uses thereof
HK1206725A1 (en) Alkynyl heteroaromatic ring compound and application thereof
IL251974B (en) Antifibrosis compounds and their uses
EP2806872A4 (en) BENDAMUSTIN COMPOSITIONS AND RELATED METHODS
ZA201501124B (en) Trans-clomiphene formulations and uses thereof
HK1202445A1 (en) New formulation
HK1201270A1 (en) Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5--
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
GB2502110B (en) Chips and manufacture thereof
ZA201500518B (en) Shampoo composition
HK1207852A1 (en) Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors
PL2882708T3 (pl) Nowe związki i ich zastosowania
EP2837632A4 (en) COMPOUND JK12A AND ITS PREPARATION
LT2830587T (lt) Odą apsauganti ir odos pusiausvyrą palaikanti kompozicija
GB201206998D0 (en) New compound and uses
GB201207075D0 (en) New compounds and uses
GB201206973D0 (en) New compounds and uses
GB201206055D0 (en) New compounds and uses
GB201214749D0 (en) Compounds and their uses
GB201222342D0 (en) Compounds and uses thereof
GB201213726D0 (en) Novel compounds and their use